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Cardiac hemangioma is one of the rare benign primary cardiac tumors 
with an incidence of 1% to 2%. To date, less than 15 cases of cardiac 
hemangioma causing RVOT obstruction have been reported.
(2) Posterior Mediastinal Vascular Malformation: A rare case of a 27-
year-old male with an incidental ﬁnding of a right lung mass on chest 
radiograph and was conﬁrmed as a posterior mediastinal mass on CT 
scan. The patient underwent thoracotomy to debulk the tumor, how-
ever, the procedure was aborted due to tremendous bleeding. The tissue 
samples submitted revealed an arteriovenous malformation and was 
conﬁrmed on special and immunohistochemical staining. The patient 
was then scheduled for angiogram and embolization.
Most tumors of the posterior mediastinum are neurogenic in origin. An 
arteriovenous malformation in the posterior mediastinum is a very rare 
neoplasm with only 2 reported cases. To the best of our knowledge, this 
seems to be the third reported case of posterior mediastinal arteriove-
nous malformation (AVM).
(3) Pulmonary Sclerosing Hemangioma: A rare case diagnosed by 
frozen section biopsy in a 41 year old asymptomatic female who pre-
sented with a solitary pulmonary nodule discovered on routine annual 
medical chest radiograph. Immunohistochemical stains such as Thyroid 
Transcription Factor I (TTFI), Epithelial Membrane Antigen (EMA) 
and Cytokeratin were done. 
Pulmonary Sclerosing Hemangiomas are rare, slowly growing benign 
neoplasms of uncertain histogenesis. 
Results: Vascular lesions are difﬁcult to diagnose for the inexperienced 
pathologist, clinician and thoracic surgeon. These lesions must be 
properly evaluated prior to any surgical procedure to prevent further 
complications such as bleeding. For pathologists, differentiating hem-
angiomas from other vascular tumors are difﬁcult because most often 
and commonly in these three presented cases, biopsy material sent to 
the laboratory is inadequate and not representative of the entire mass. 
With minimal surgical specimen, the pathologist was able to conﬁrm 
the benign nature of the lesion with immunohistochemical stains such 
as CD 31, S100, Factor VIII and elastic stain.
Conclusion: We have presented three thoracic vascular tumors to 
increase the awareness that although these tumors are rare and histo-
logically benign, they may be life-threatening. Its treatment requires 
careful judgment and multidisciplinary team approach with the thoracic 
surgeon, cardiologist, pulmonologist and pathologists as well. 
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Background: CD4+CD25+ Regulatory T cells (Tregs) have been 
shown to suppress host immune responses to a variety of cancers. 
Nuclear Foxp3 is currently the only speciﬁc marker for regulatory T 
cells. We describe the presence and pattern of Foxp3+ lymphocyte inﬁl-
tration in human non-small cell lung cancers, conﬁrming the presence 
of regulatory T cells with the hope of future immune targeted therapies.
Methods: Sixteen cases of formalin ﬁxed parafﬁn embedded lung 
tissue were selected from the pathology archives, [13 primary lung car-
cinomas (5 squamous cell carcinoma, 4 adenocarcinoma, 3 adenocar-
cinoma with bronchoalveolar features (BACF), and 1 bronchoalveolar 
carcinoma (BAC), 2 inﬂammatory (1 bronchiectasis and 1 interstitial 
ﬁbrosis) and 1 metastatic thyroid carcinoma]. Ages were 39-83 years, 
there were 10 women. The tissue was incubated with 1:50 dilution 
of puriﬁed anti-Foxp3 antigen (Biolegend). The amount of lymphoid 
stroma was measured as the percent of lymphoid tissue within 10 tumor 
high power ﬁelds (hpf- 20x).The percent of Foxp3 positive lympho-
cytes within each lymphoid aggregate was measured as percent positive 
per aggregate (40x). These were multiplied to give a Treg expression 
index (Foxp3 expression/aggregate)(number of aggregates).
Results: Squamous carcinoma had the least amount of lymphoid tissue 
(4.2%) and BAC/BACF had the greatest (6%). The greatest number of 
Tregs per hpf lymphoid tissue was in the metastasis (40/ﬁeld) and least 
in inﬂammation (17.5/ﬁeld). The highest Treg index was in the case of 
pulmonary metastasis (200). Of the primary lung tumors, adenocarcino-
ma (181), BAC (162) and BACF (146) were the highest. Inﬂammation 
(96.2) and squamous carcinoma (83.2) were at the low end. No trend 
was identiﬁed regarding location of lymph tissue at the tumor interface 
or within the tumor. 
Conclusions: All lymphoid aggregates showed a sprinkling of Foxp3 
positive nuclei suggesting that Tregs are present in all inducible lym-
phoid tissue, with variations in tumor type and total lymphoid quantity. 
Tumors that induced a greater amount of lymphoid stroma tended to 
have the greatest Foxp3 index. We did not ﬁnd any case without at least 
scant Treg presence. Future immune directed therapeutic intervention 
may be possible after understanding the presence and pattern of these 
cells in non-small cell lung cancers.
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Background: Survivin is a member of the inhibitors of apoptosis (IAP) 
gene family that acts through pathways different from those involving 
the bcl-2 family. Largely undetectable in normal adult tissues, survivin 
is deregulated in most human cancers including non-small-cell lung 
cancer (NSCLC) and may represent a tumor marker with prognostic 
and therapeutic implications. Aim of our study was to determine the 
prognostic role of survivin as an apoptosis-related biomarker in a series 
of early-stage NSCLC patients.
Methods: A retrospective series of resected NSCLC patients was 
retrieved from the ﬁles of the Regina Elena National Cancer Insti-
tute. Survivin was detected by immonohistochemistry (IHC) using a 
polyclonal antibody. Survivin displayed two kinds of immunoreactiv-
ity: a diffuse cytoplasmic staining and a distinct nuclear staining. A 
score-scale to distinguish positive (score 1-2) versus negative (score 0) 
pattern was applied. Clinical and biological (nuclear and cytoplasmic 
survinin staining) covariables were screened for a prognostic rela-
tionship with overall (OS) and progression free-survival (PFS) into a 
univariate and multivariate analysis. 
Results: Data referring to 116 NSCLC patients who underwent surgery 
for stage I-IIIA NSCLC were collected. Multivariate analyses identiﬁed 
tumor size, nodal status and nuclear, but not cytoplasmic, expression 
of survivin as signiﬁcant independent predictors of OS, with an hazard 
